Steris (STE) EBT Margin (2018 - 2026)
Steris' quarterly EBT Margin came in at 17.23% in Q4 2025, up 54.0% year-on-year from 11.19% in Q4 2024, and down 0.59% quarter-over-quarter from 17.33% in Q3 2025.
Steris has reported EBT Margin for 8 years, with the latest figure at 17.23% in Q4 2025.
- For the quarter ending Q4 2025, EBT Margin rose 54.0% year-over-year to 17.23%; the trailing twelve-month figure through Dec 2025 stood at 16.13% (up 151.0% YoY), and the FY2025 full-year result was 14.58%, up 91.0% from the prior year.
- EBT Margin for Q4 2025 stood at 17.23%, down from 17.33% in the prior quarter.
- The five-year high for EBT Margin was 17.33% in Q3 2025, with the low at 2.99% in Q2 2021.
- Average EBT Margin over 5 years is 13.47%, with a median of 14.61% recorded in 2022.
- Year-over-year, EBT Margin tumbled 1923 bps in 2021 and jumped 1688 bps in 2022.
- Tracing STE's EBT Margin over 5 years: stood at 15.09% in 2021, then increased by 2 bps to 15.42% in 2022, then declined by 5 bps to 14.61% in 2023, then increased by 14 bps to 16.69% in 2024, then gained by 3 bps to 17.23% in 2025.
- The last three EBT Margin figures came in at 17.23% (Q4 2025), 17.33% (Q3 2025), and 16.67% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 14.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.17% |
| Dec 31, 2025 | 17.23% |
| Sep 30, 2025 | 17.33% |
| Jun 30, 2025 | 16.67% |
| Mar 31, 2025 | 13.33% |
| Dec 31, 2024 | 16.69% |
| Sep 30, 2024 | 14.67% |
| Jun 30, 2024 | 13.69% |
| Mar 31, 2024 | 13.43% |
| Dec 31, 2023 | 14.61% |
| Sep 30, 2023 | 12.59% |
| Jun 30, 2023 | 14.09% |
| Mar 31, 2023 | 15.88% |
| Dec 31, 2022 | 15.42% |
| Sep 30, 2022 | 14.60% |
| Jun 30, 2022 | 13.88% |
| Mar 31, 2022 | 10.22% |
| Dec 31, 2021 | 15.09% |
| Sep 30, 2021 | 7.49% |
| Jun 30, 2021 | -2.99% |
| Mar 31, 2021 | 15.53% |
| Dec 31, 2020 | 17.24% |
| Sep 30, 2020 | 17.69% |
| Jun 30, 2020 | 16.24% |
| Mar 31, 2020 | 17.99% |
| Dec 31, 2019 | 17.30% |
| Sep 30, 2019 | 15.92% |
| Jun 30, 2019 | 14.27% |
| Mar 31, 2019 | 17.31% |
| Dec 31, 2018 | 8.30% |
| Sep 30, 2018 | 14.03% |
| Jun 30, 2018 | 13.00% |
| Mar 31, 2018 | 40.83% |